相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma
Amanda Tivnan et al.
BMC CANCER (2011)
CAMTA1, a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells
Kai-Oliver Henrich et al.
CANCER RESEARCH (2011)
Recurrent Interstitial 1p36 Deletions: Evidence for Germline Mosaicism and Complex Rearrangement Breakpoints
Marzena Gajecka et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
Telomeric Strategies: Means to an End
Devanshi Jain et al.
ANNUAL REVIEW OF GENETICS, VOL 44 (2010)
The Oncoprotein c-Ski Functions as a Direct Antagonist of the Transforming Growth Factor-β Type I Receptor
Nathalie Ferrand et al.
CANCER RESEARCH (2010)
Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis
K-John J. Cheung et al.
CANCER RESEARCH (2010)
High Resolution Analysis of Follicular Lymphoma Genomes Reveals Somatic Recurrent Sites of Copy-Neutral Loss of Heterozygosity and Copy Number Alterations that Target Single Genes
K-John J. Cheung et al.
GENES CHROMOSOMES & CANCER (2010)
RHOA and PRKCZ control different aspects of cell motility in pancreatic cancer metastatic clones
Marco Della Peruta et al.
MOLECULAR CANCER (2010)
Perspectives on RUNX Genes: An Update
M. Michael Cohen
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances
K. -John J. Cheung et al.
BLOOD (2009)
A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36
Tiemo Katzenberger et al.
BLOOD (2009)
Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation
Derville O'Shea et al.
BLOOD (2009)
miR-34a as part of the resistance network in chronic lymphocytic leukemia
Thorsten Zenz et al.
BLOOD (2009)
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Mathew E. Sowa et al.
CELL (2009)
Microarray-Based Genomic Profiling Reveals Novel Genomic Aberrations in Follicular War Lymphoma Which Associate with Patient Survival and Gene Expression Status
Carsten Schwaenen et al.
GENES CHROMOSOMES & CANCER (2009)
Further delineation of nonhomologous-based recombination and evidence for subtelomeric segmental duplications in 1p36 rearrangements
Carla S. D'Angelo et al.
HUMAN GENETICS (2009)
Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer
Min Ah Kang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells
G. Tilman et al.
ONCOGENE (2009)
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene
Kristina A. Cole et al.
MOLECULAR CANCER RESEARCH (2008)
Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas
E. R. Okawa et al.
ONCOGENE (2008)
Genetic and epigenetic changes in the common Ip36 deletion in neuroblastoma tumours
H. Caren et al.
BRITISH JOURNAL OF CANCER (2007)
Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis
Charles W. Ross et al.
CLINICAL CANCER RESEARCH (2007)
Identification of novel RUNXI (AMLI) translocation partner genes SH3D19, YTHDF2, and ZNF687 in acute myeloid leukemia
TuDung T. Nguyen et al.
GENES CHROMOSOMES & CANCER (2006)
Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia
C Mayr et al.
BLOOD (2006)
Novel RUNXI-PRDMI6 fusion transcripts in a patient with acute myeloid leukemia showing t(I;2 I)(p36;q22)
I Sakai et al.
GENES CHROMOSOMES & CANCER (2005)
Del 1p36 syndrome: a newly emerging clinical entity
A Battaglia
BRAIN & DEVELOPMENT (2005)
FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome
I Lahortiga et al.
HUMAN GENETICS (2005)
Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies
MD Odero et al.
LEUKEMIA (2005)
Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas
M Höglund et al.
GENES CHROMOSOMES & CANCER (2004)
The p73 locus is commonly deleted in non-Hodgkin's lymphomas
A Stoffel et al.
LEUKEMIA RESEARCH (2004)
Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p
N Mori et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Detection by fluorescence in situ hybridization of microdeletions at 1p36 in lymphomas, unidentified on cytogenetic analysis
A Rajgopal et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis
VS Lestou et al.
GENES CHROMOSOMES & CANCER (2003)
Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas
B Martinez-Delgado et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome
MD Odero et al.
GENES CHROMOSOMES & CANCER (2002)
Frequent loss of heterozygosity in the region of D1S450 at 1p36.2 in myelodysplastic syndromes
WK Hofmann et al.
LEUKEMIA RESEARCH (2001)